Company Info
Phone(857) 285-6200
Year Established
2014
Contacts
John Leonard, M.D.President & CEO
Edward Dulac
CFO
David Lebwohl, M.D.
CMO
James Basta, J.D.
General Counsel
Laura Sepp-Lorenzino, Ph.D.
CSO
Derek Hicks
CBO
Company Description
Intellia Therapeutics is a leading clinical-stage genome editing company, focused on the development of proprietary, potentially curative therapeutics using the CRISPR/Cas9 system.